Regulatory mechanisms of interleukin-10 (IL10)-producing B cells in mucosal homeostasis are not fully understood. This study shows that IL10-secreting B cells activated by resident bacteria ameliorate T-cell-mediated colitis by inducing T regulatory-1 cells via an IL27-dependent mechanism.
BACKGROUND & AIMS:
The regulatory roles of interleukin-10 (IL10)-producing B cells in colitis are not fully understood, so we explored the molecular mechanisms by which these cells modulate mucosal homeostasis.
METHODS: CD4
þ T cells from wild-type (WT), Il10 
CD4
þ Treg prevent colitis in severe combined immunodeficiency mice cotransferred with CD45RB high T cells, 5 and enteric bacterial antigen-specific Tr-1 cells ameliorate colitis induced by pathogenic T helper 1 (T H 1) cells. 6 In parallel with Treg cells, B cells contribute to intestinal homeostasis by secreting immunoglobulins that decrease mucosal translocation of luminal bacteria and producing regulatory cytokines that inhibit effector mucosal immune responses. 7 Moreover, antigen presentation by B cells promotes the differentiation of tolerogenic CD4 þ T cells. 8 B-cell depletion may contribute to the development of human IBD 9 and potentiate murine experimental colitis, 10 ) and IL10-receptor-deficient mice develop resident enteric bacteria-dependent T H 1/T H 17-mediated colitis. 12 The role of IL10 derived from intestinal T-cells and myeloid cells in maintaining mucosal homeostasis is well studied, but relatively little is known about the importance of IL10-producing B cells in IBD and experimental colitis. 9, 10, 13, 14 Moreover, the mechanisms of how IL10-producing B cells potentially maintain mucosal homeostasis in the intestine are poorly understood.
IL27, a member of the IL12 family, consists of EpsteinBarr virus induced gene-3 (EBI3) and p28 subunits and has pleiotropic effects on the immune system. IL27 was originally reported to induce T H 1 cell development, 15 but it can also suppress the development of T H 17 cells by decreasing Rorgt gene expression and increasing the number of IL10-producing Tr-1 cells but not Foxp3
þ Treg. [16] [17] [18] [19] [20] IL27 promotes the expansion of Tr-1 cells by upregulating c-Maf and aryl hydrocarbon receptor in naïve T cells. 20 There is conflicting evidence regarding the role of IL27 in colitis, with some studies showing that IL27 has proinflammatory effects [21] [22] [23] and others demonstrating that IL27 is anti-inflammatory. [24] [25] [26] Thus, IL27 likely plays a pivotal role in regulating the delicate balance between proinflammatory T H 1/T H 17 cells and anti-inflammatory IL10-producing T-cell populations in the intestine. However, it is unknown whether IL10-producing mucosal B cells affect the regulatory or proinflammatory functions of IL27.
This study addresses the mechanisms by which IL10-secreting B cells influence regulatory T-cell differentiation and ameliorate T-cell-mediated colitis. We show that IL10-producing B cells suppress wild-type (WT) but not Il10 À/À CD4 þ T-cell-mediated colitis and are associated with increased frequency of intestinal Tr-1 cells and decreased T H 1/T H 17 cytokine profiles. Moreover, we demonstrate that regulatory functions of IL10-secreting B cells are mediated by IL27-signaling in T cells. Together, these findings elucidate novel regulatory mechanisms of IL10-secreting B cells, help explain mechanisms of mucosal homeostasis, and could be exploited to treat IBD.
Materials and Methods

Mice
We purchased C57BL/6 (B6 , DKO, and Vert-X mice were derived into germ-free (GF) conditions by embryo transfers, and breeding colonies were established in the GF facility at the UNC. Afterward, the mice were transferred to a SPF room and colonized with SPF feces to maintain SPF colonies. The mice used in this study were born from parents that had also been born and raised in SPF conditions over six generations, and they were used at 8 to 16 weeks of age. These studies were approved by the UNC-Chapel Hill Institutional Animal Care and Use Committee (ACUC) Protocol no. 12-300.0.
Cell Isolation
Mononuclear cells were isolated from the colon lamina propria (LP), mesenteric lymph nodes (MLN), and spleen, as described elsewhere. 13 The MLN were pressed through 70-mm filters into phosphate-buffered saline (PBS) with 2.5% fetal bovine serum (Gibco/Invitrogen, Carlsbad, CA). Spleens were mechanically dissociated, and the red blood cells were lysed with red blood cell lysing buffer (SigmaAldrich, St. Louis, MO). For isolation of colonic LP lymphocytes (LPL), the large intestines were washed with cold PBS, opened longitudinally, and cut into 10-mm pieces. Then the intestines were incubated in 1 mM dithiothreitol (SigmaAldrich) in Ca 2þ -and Mg 2þ -free Hanks' balanced salt solution (HBSS; Gibco/Invitrogen) for 15 minutes at room temperature. Next, the tissues were incubated in 1 mM EDTA (Sigma-Aldrich) in HBSS for 20 minutes at 37 C with shaking, which was repeated after a thorough washing. The cell suspensions were removed, and the remaining fragments were transferred to flasks containing HBSS with 1 mg/mL of collagenase type 3 (Sigma-Aldrich) and 1% penicillin-streptomycin (Gibco/Invitrogen), then stirred gently for 60 minutes at 37 C. The cell suspensions containing LPL were filtered through a nylon mesh and centrifuged, then the LPL were purified using a 44%-70% discontinuous Percoll gradient (GE Healthcare, Buckinghamshire, UK). After centrifugation at 800g for 20 minutes at 22 C, the mononuclear cells were collected from the interface.
Cell Purification
Splenic B cells were purified magnetically by positive selection with anti-CD19 microbeads after negative selection by a mixture of anti-CD90. À/À donors. The severity of colitis and intestinal cell populations were assessed 3 to 6 weeks after the cell transfer.
Assessment of Colitis
We evaluated the severity of colitis by blinded histologic scoring, colonic tissue explant cultures, and MLN cell cultures, as described elsewhere. 28 Blinded histologic scoring. Intestinal tissues were removed and fixed in 10% buffered formalin. Histologic inflammation was quantified in paraffin-embedded, H&E-stained sections of cecum, proximal colon, and distal colon in a blinded fashion, with each region being graded from 0 to 4 based on the degree of LP and submucosal mononuclear cellular infiltration, crypt hyperplasia, goblet cell depletion, and architectural distortion. The total histology score represents the summation of the scores for cecum, proximal colon, and distal colon (maximum score 12).
Colonic tissue explant cultures. Colonic tissues ware thoroughly washed with cold PBS, shaken at room temperature in RPMI containing 50 mg/mL gentamicin for 30 minutes at 280 rpm, cut into 0.5-cm fragments, and weighed. Colonic tissue fragments were distributed (0.05 g per well) into 24-well plates and incubated in 1 mL of RPMI 1640 medium supplemented with 5% fetal bovine serum, 50 mg/mL gentamicin, and 1% antibiotic/antimycotic (penicillin/streptomycin/amphotericin B; GIBCO, Grand Island, NY) for 20 hours at 37 C. Supernatants were collected and stored at À20 C before use for cytokine quantification.
Mesenteric lymph node cell cultures. The 5 Â 10 5 unfractionated MLN cells of individual recipient animals were stimulated in 96-well flat-bottom plates with 10 mg/mL CBL at 37 C, 5% CO 2 in a humidified incubator. After 72 hours, the culture supernatants were collected for cytokine assays.
Cecal Bacterial Lysate
Cecal bacterial lysate (CBL) was prepared from the contents of ceca from SPF B6 or 129.WT mice as described elsewhere. 28 The protein concentration of the lysate was determined, and the cells were stimulated with 10 mg/mL of protein. In selected experiments, 10 mg/mL anti-IL10R neutralizing antibody (BD Biosciences, San Jose, CA), anti-IL27 neutralizing antibody (eBioscience, San Diego, CA), isotype control [purified rat IgG1 (BD Biosciences) or mouse IgG2a (eBioscience)], or recombinant murine IL10 or IL27 at 10, 1, or 0.1 ng/mL (PeproTech, Rocky Hill, NJ) was added. After 72 hours, the supernatants were collected for measurement of cytokines by enzyme-linked immunosorbent assay (ELISA), and cells were analyzed by flow cytometry. For bacteria-activated T-cell RNA analysis, CBL-stimulated naïve T cells were reisolated using a 
Il10
À/À mice. Six weeks later, colonic inflammation was quantified by (A) histology (total and segmental scores), photomicrographs (B), and cytokine-secretion from unstimulated colon explant cultures (C) and from cecal bacterial lysate (CBL)-stimulated mesenteric lymph nodes (MLN) cell cultures (D). MLN cells were evaluated for (E) the reconstitution of
þ T-regulatory cells by flow cytometry. mRNA level of Foxp3 in the distal colon was assessed by real-time polymerase chain reaction. N ¼ 6-7/group, two replicates. Data are presented as mean ± standard error. *P < .05; **P < .01; ***P < .001.
CD4
þ T-cell isolation kit with LD columns (Miltenyi Biotec) 24 hours after coculture with B cells and APC.
Cytokine Measurements
To evaluate the production of cytokines, ELISAs were performed by the Immunoassay Core of the CGIBD at UNC according to the manufacturer's instructions with the following products: mouse anti-IL10, IL12/23p40, interferon-g (IFNg), and IL17 (BD Biosciences), and IL27 (eBioscience). Concentrations of cytokines were established in triplicate culture supernatants by comparison with standard curves generated using the appropriate recombinant cytokine.
Real-Time Polymerase Chain Reaction
Total RNA was isolated from reisolated CD4 þ cells using RNeasy Micro Kit (Qiagen, Valencia, CA) and real-time polymerase chain reaction (RT-PCR) was performed as described elsewhere. 28 The primer sequences used in this study are shown in Table 1 .
Flow Cytometry
The antibodies we used in this study were anti-mouse CD4, CD19, CD45, B220, CD3, F4/80, CD11c, CD11b (BD Bioscience), IL10, IL17, IFNg, IL27p28, and Foxp3 (eBioscience), eBi3 (R&D Systems, Minneapolis, MN), and live/dead cell viability kits (Invitrogen/Life Technologies, Carlsbad, CA). MLN, or colonic LP cells were collected and incubated for 15 minutes at 4 C with anti-CD16/CD32 (BD Bioscience) and then for 20 minutes at 4 C with antibodies for cell surface and live/dead cell viability kits to evaluate the cell phenotype and CD4 þ T-cell/B-cell reconstitution.
Enumeration of cells expressing IL10, IL17, IFNg, IL27p28, Ebi3, and Foxp3 was performed by intracellular staining with a fixation and permeabilization solution kit (BD Bioscience) according to the manufacturer's instructions. For intracellular cytokine staining, 100 ng/mL phorbol myristate acetate, 1 mg/mL ionomycin (Sigma-Aldrich), and GolgiStop (BD Biosciences) were added into the medium during the last 4 hours of the culture period. The cells were washed and then analyzed on a CyAn flow cytometer (Beckman Coulter, Brea, CA). Proper isotype antibodies were used as a control, and gated live CD45 þ cells were analyzed with Summit 5.2 software (Beckman Coulter).
Statistical Analysis
Statistical analysis was performed using Prism 5 software (GraphPad, San Diego, CA) to compare the mean between two groups with two-tailed, unpaired Student's t tests; comparisons of the mean from multiple groups were analyzed with one-way analysis of variance (ANOVA) and the Bonferroni posttest. P < .05 was considered statistically significant. À/À mice into SPF 129.Rag2 À/À Il10 À/À mice. Six-weeks later, histologic total colon inflammation scores (A) and IFNg-secretion in colon explant cultures (B) were measured. N ¼ 6-7/group, two replicates. Data are presented as mean ± SE, *P < .05, **P < .01, ***P < .001 (n ¼ 6-7/group). N.S: not statistically significant.
Results
Interleukin
We found that the percentages of T and B cells in MLN from mice that received WT B cells were not statistically significantly different compared with the percentages in those that received Il10 À/À B cells ( Figure 1E ). The percentages of MLN Foxp3 þ
CD4
þ Treg and Foxp3 mRNA levels in the distal colon were statistically significantly increased in the mice that received either WT or Il10 À/À B cells compared with the mice that did not receive B cells ( Figure 1F ). On the other hand, cotransfer of WT B cells had no effect on histologic inflammation or IFNg-secretion by colonic tissue explants in mice that received Il10
þ T cells even when 10 times more WT B cells were transferred (Figure 2A and B) , suggesting that IL10-producing B cells inhibit experimental colitis caused by T-cell-transfer only when the T cells are capable of secreting IL10. Moreover, the B cells from the GF and SPF B6.WT mice exhibited similar anti-inflammatory properties ( Figure 3A and B). Our transferred CD19 þ
B220
þ population that contained mainly naïve B cells, even in SPF mice (more than 95%), received physiologic bacteria stimulation in SPF recipients to stimulate IL10-secretion and regulatory function. On the other hand, B cells from noninflamed GF and inflamed SPF B6.Il10
À/À mice similarly lacked anti-inflammatory properties in vivo and in vitro, suggesting that the difference in colitis between mice that received WT versus Il10 À/À B cells is not due to the preexistence of inflammation in the Il10 À/À donor mice ( Figure 3A and B) . À/À mice housed in GF or SPF conditions along with 2 Â 10 5 GF Il10 À/À Antigen-presenting cells 48 hours later, cytokines in the supernatant were measured by enzyme-linked immunosorbent assay (ELISA). N ¼ 6/group, two replicates. Mean ± SE, *P < .05; **P < .01; ***P < .001.
Physiologically Activated Interleukin-10-Producing B Cells Inhibit Proinflammatory Cytokine-Secretion by T Cells In Vitro
We next sought to determine mechanisms by which IL10-producing B cells inhibit proinflammatory cytokinesecretion by T cells. We measured cytokines in physiological CBL-stimulated cocultures of unfractionated CD4 þ T and B cells from 129.WT or Il10 À/À mice and Il10 À/À APC. We detected increased IL10 in cultures containing WT B cells and the amounts were even higher when cocultured with WT or Il10 À/À T cells ( Figure 4A ). In cultures containing WT CD4 þ cells, the presence of IL10-producing B cells was associated with decreased levels of IFNg and IL17a compared with cultures that had Il10 À/À or no B cells ( Figure 4A and 4B) . In contrast, consistent with the inability of WT B cells to attenuate experimental colitis in the absence of IL10-producing T cells, WT B cells were unable to suppress IFNg and IL17a when cocultured with Il10 À/À T cells ( Figure 4A and B) . Blockade of IL10-signaling by anti-IL10R antibody increased IFNg-secretion in the cultures containing WT CD4 þ T cells, WT B cells, and Il10 À/À APC, whereas exogenous recombinant-IL10 decreased IFNg and IL17a-secretion in the cultures containing Il10
À/À B cells with Il10 À/À APC. These data indicate that the anti-inflammatory function of IL10-producing B cells may be due in part to their ability to suppress IFNg and 
CD4
þ Treg were analyzed by flow cytometry (D). Mean ± standard error. *P < .05; **P < .01; ***P < .001. 
þ T cells ( Figure 4C ). The majority of IL10-positive cells in the cultures containing WT CD25
, and WT B cells were B cells ( Figure 4D ). The WT but not Il10 À/À B cells suppressed IFNg-production by CD25 -CD4þ T cells to a similar degree as WT or Il10
þ Treg and WT B cells each suppressed IFNg-secretion, and when added together, the degree of suppression was greater ( Figure 4C ). On the other hand, the presence of Il10 À/À B cells enhanced IFNg-production by both CD25
þ T cells compared with no B cells ( Figure 4C ). These data suggest that IL10-producing B cells inhibit T H 1 function to a similar degree as CD25 Figure 6A ) and upregulated Il10 mRNA expression in reisolated CD4 þ T cells ( Figure 6B ). The frequency of Tr-1 cells and IL10-secretion increased and IFNg and IL17a-secretion decreased in the presence of increasing numbers of WT but not Il10 À/À B cells ( Figure 6C ). Together, these data suggest that the regulatory capability of IL10-producing B cells is due in part to their ability to inhibit differentiation of certain effector T-cell subtypes and promote differentiation of discrete regulatory T cell subtypes, including Tr-1 cells.
Whether the observed regulatory features of IL10-producing B cells, including the expansion of Tr-1 cells, À CD4 þ T cells and Il10 À/À APC. Cells were stimulated with cecal bacterial lysate for 72 hours and supernatant levels of IL10, interferon-g (IFNg) and IL17a were measured by enzyme-linked immunosorbent assay (ELISA). N ¼ 9/group, three replicates; mean ± standard error. *P < .05; **P < .01.
was directly due to secreted IL10 or indirectly due to other factors remains unknown. Therefore, we quantified the development of Tr-1 cells in CBL-stimulated cocultures of CD25 À/À Il10 À/À mice were assessed by flow cytometry (CD4 þ cells gated). N ¼ 8-9/group, two replicates; mean ± standard error. **P < .01; ***P < .001. D) . N ¼ 8-9/group, two replicates; mean ± standard error. *P < .05; **P < .01. Because IL27 is implicated in the development of Tr-1 cells, we sought to identify the cell-type that secretes IL27 in our in vitro coculture system. Although others have previously identified myeloid cells as the primary source of IL27, 15 we detected IL27-secretion by CBL-stimulated B cells, with no difference between Il10 À/À and WT cells ( Figure 11A ). We also found markedly higher levels of IL27 with cocultured Il10 À/À APC and Il10 À/À B cells, which was abrogated by recombinant IL10. Moreover, the addition of anti-IL10R-blocking antibody to cocultured WT B cells and WT APC enhanced IL27-secretion ( Figure 11A) Figure 11B and C) . Together, these data indicate that CBL induces B cells to secrete IL27, especially in the presence of APC and absence of IL10, and that IL10, regardless of the source, controls IL27 secretion.
Discussion
We demonstrate a key role for physiologically stimulated IL10-secreting B cells in mucosal immune homeostasis and provide a mechanism by which resident intestinal microbial components induce IL10-dependent regulatory immune responses that prevent intestinal inflammation. Our in vivo data show that IL10-producing B cells ameliorate T-cell-mediated experimental colitis depending on IL10-production by both cotransferred B cells and CD4 þ T cells in the absence of IL10-producing APC.
Previous 
CD4
þ Tr-1-like cells. 39 These studies addressed the importance of IL10-producing B cells to control effector and regulatory T cells. Therefore, we focused on the key mechanisms by which IL10-producing but not Il10 À/À B cells induced Tr-1 cells in IBD. Key findings of our study were that physiologically stimulated IL10-secreting B cells induce mucosal Tr-1 cells in an IL27-signaling-dependent manner and decrease T H 1/T H 17 immune responses. The biologic role of IL27 in IBD remains uncertain because IL27 has been implicated as both a proinflammatory and antiinflammatory cytokine. [22] [23] [24] [25] [26] [27] However our data suggest that these pleiotropic protective and inductive effects may be due to different timing or concentrations of IL27 and variable presence of IL10 in the various colitis models. B cells appear to optimally control the regulatory functions of T cells by secreting IL10 with small amounts of IL27, but high concentrations of IL27, particularly in the absence of IL10, enhance IFNg production.
Because IL10-producing myeloid cells can also induce In conclusion, physiologically activated IL10-secreting B cells regulate mucosal inflammation by multiple mechanisms: suppressing effector APC:T cell activity, decreasing proinflammatory cytokine production, and expanding Tr-1 cells in association with immunosuppressive amounts of IL27 (Figure 12) .
B cells induce Foxp3
þ Treg in an IL10-independent manner, but this is not sufficient to maximally protect against colitis. Overall, IL10-secreting B cells have an important role in regulating T-cell function and ameliorating T-cell-mediated colitis. These findings provide new insights into the mechanisms of intestinal immune homeostasis and may provide new targets for IBD therapies.
